Evaluation of Medication- Assisted Treatment (MAT) for Opioid Use Disorders Study

ICR 201812-0920-002

OMB: 0920-1218

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Justification for No Material/Nonsubstantive Change
2018-12-07
Supplementary Document
2018-02-12
Supplementary Document
2018-02-12
Supplementary Document
2018-02-12
Supporting Statement A
2018-02-12
Supplementary Document
2017-11-08
Supporting Statement B
2018-02-12
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
Supplementary Document
2017-11-08
ICR Details
0920-1218 201812-0920-002
Historical Active 201711-0920-009
HHS/CDC 0920-19GX
Evaluation of Medication- Assisted Treatment (MAT) for Opioid Use Disorders Study
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 12/19/2018
Retrieve Notice of Action (NOA) 12/10/2018
Approved consistent with the understanding that CDC will continue to coordinate opioid research efforts and outcomes with partners both within HHS and external (SAMHSA, NIH/NIDA, FDA)
  Inventory as of this Action Requested Previously Approved
02/28/2021 02/28/2021 02/28/2021
6,871 0 6,871
3,093 0 3,093
0 0 0

Conduct an epidemiologic study to assess the real-world client outcomes of three types of Medication Assisted Treatment (MAT) and counseling without medication for individuals with Opioid Use Disorder (OUD). This study will also examine the contextual, provider, and individual factors that influence treatment implementation and client outcomes.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

  82 FR 27832 06/19/2017
82 FR 57757 12/07/2017
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,871 6,871 0 0 0 0
Annual Time Burden (Hours) 3,093 3,093 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
This is a new ICR.

$1,940,535
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Kevin Joyce 404 639-1944 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/10/2018


© 2024 OMB.report | Privacy Policy